A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease | Science Translational Medicine
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial - The Lancet Respiratory Medicine
Spatially Distributed Amyloid- Reduces Glucose Metabolism in Mild Cognitive Impairment
The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases | Science Advances
Grupele de sange si factorul RH | Bioclinica
Frontiers | The Correlation Between White Matter Hyperintensity Burden and Regional Brain Volumetry in Patients With Alzheimer's Disease
Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer's disease | eLife
CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies - Chey - WIREs Mechanisms of Disease - Wiley Online Library
Analize de sange - Analize de laborator | Bioclinica
Bioclinica - Analize Medicale de Laborator | +100 Puncte de Recoltare
Subthreshold Amyloid Predicts Tau Deposition in Aging
Frontiers | Apolipoprotein E ε4 Allele-Based Differences in Brain Volumes Are Largely Uniform Across Late Middle Aged and Older Hispanic/Latino- and Non-Hispanic/Latino Whites Without Dementia
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD -
Therapeutic developments for Duchenne muscular dystrophy | Nature Reviews Neurology
Ghid clinic de analize | Bioclinica
High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis - eClinicalMedicine
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease | Communications Biology
Ac anti Rh (D) | MedLife
Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia | Hypertension
ADUCANUMAB: APPROPRIATE USE RECOMMENDATIONS • The Journal of Prevention of Alzheimer's Disease
Frontiers | Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women With Alzheimer's Disease
Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia | Hypertension
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease | Nature Genetics
A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages | Translational Psychiatry
